Associate Director, Clinical Supply Chain Planning – Alpha-9 Oncology – Jobs in Boston, MA | OpenJobs AI

Which company is this position for?

Alpha-9 Oncology

Job Details

Overview Company

Associate Director, Clinical Supply Chain Planning

Alpha-9 Oncology

2 days ago

Highlight

HybridFull-timeMid

Summary

Alpha-9 Oncology is seeking an Associate Director, Clinical Supply Chain Planning to join their team in Boston, MA. The role involves leading clinical drug product supply scheduling and collaborating with cross-functional teams to optimize demand planning and S&OP strategies.

About the Role

As the Associate Director, Clinical Supply Chain Planning, you will lead all aspects of clinical drug product supply scheduling for assigned studies/programs. You will utilize advanced analytics and forecasting methods to optimize scheduling processes, create and maintain forecasts, and partner with manufacturing and quality teams to ensure timely delivery of clinical supplies. Additionally, you will develop KPIs, facilitate the implementation of the IRT system, and participate in cross-functional meetings to ensure an executable supply strategy.

About You

Required:

BS/BA degree in a related discipline.
5+ years in pharma, biotech, or FDA-regulated industries, including 1-3 years of line management experience in Clinical Supply Management or a related field.

Preferred:

Experience with radiopharmaceuticals or the distribution of Class 7 Dangerous Goods, including import/export.
Solid understanding of pharmaceutical development, manufacturing, packaging, and labeling.
Global clinical trial experience across phases 1-3.

Benefits

Competitive salary and bonus.
Equity options.
20 vacation days and 5 sick days.
Technology allowance and commuter reimbursement.
Generous retirement savings plans with employer matching.
Extended health benefits and paid holidays.

Alpha-9 Oncology

Alpha-9 Oncology is a clinical stage, radiopharmaceutical company developing differentiated and highly targeted radiopharmaceuticals with the potential to meaningfully improve the treatment of people living with cancer. Applying proprietary technologies and deep-foundational expertise, Alpha-9 is on the forefront of engineering bespoke radiopharmaceuticals that are optimized to selectively deliver radiation to tumor sites while minimizing off-target effects. Alpha-9 is advancing a robust pipeline of novel radiopharmaceuticals with a systematic approach to molecule design that offers broad potential for expansion into several validated oncology targets. Alpha-9 was founded by researchers from the University of British Columbia and BC Cancer, with the goal of improving the lives of patients affected by metastatic cancers.

Boston, MA